Anti-Epilepsy Drug Primidone Recalled

Health Canada is advising Canadians that AA Pharma Inc. is voluntarily recalling two lots of Primidone tablets because they contain high levels of lead. The company has indicated that only the lots identified below are affected by this issue. 

 

Product         Strength    DIN Size/Format   Lot Number     Expiry

Primidone      125 mg     00399310              100 tablets      MT4040 05/2021

Primidone      250 mg     00396761              100 tablets      MM3274 10/2020

 

Primidone is a prescription anti-epileptic drug used to control seizures. The high levels of Lead can pose serious health risks when too much is ingested, particularly by children, pregnant and breastfeeding women. If you have the affected Primidone return the product to your pharmacy for replacement as soon as possible. Health Canada says do not stop taking Primidone without talking to your doctor. Stopping suddenly can cause serious problems, including seizures that may not stop. 

For more information contact AA Pharma Inc. via Stericycle by calling 1-888-228-5053 or by email at AAPharma7068@stericycle.com if you have questions about this recall. 

Contact Us

If you have a news tip, story idea or to reach a radio host, contact us here.